Overview
Table of Contents
Tables and Figures
Survey Questions
Download Report Brochure
Download Sample Pages
Country or Global license Contact David Cunningham, Account Manager, 781-972-5472cunningham@healthtech.com
Length 166 pages
Date published January 2007
Additional info Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.
Ken Rubenstein, PhD
Table 1.1. GlaxoSmithKline’s Biomarker Typology Table 6.1. Purpose versus Characteristics of Diagnostics Used as Screening Tools Table 6.2. Biomarker Validation Attributes
Figure 6.1. Evolution of a New Biomarker Figure 7.1. Survey: Respondents by Sector Figure 7.2. Survey: Respondents by Position Figure 7.3. Survey: Respondents by Stage of Work Figure 7.4. Survey: Respondents by Research Focus Figure 7.5. Survey: Involvement with Biomarker Planning and Discovery Figure 7.6. Survey: View toward Precommercial Biomarker Development Figure 7.7. Survey: View toward Standard Operating Procedures or Guidelines for Biomarker Development Figure 7.8. Survey: View toward Outsourcing Biomarker Discovery and Development Figure 7.9. Survey: Reasons for Biomarker Outsourcing Figure 7.10. Survey: Types of Biomarkers Used Figure 7.11. Survey: Stage at Which Biomarkers Are Used Figure 7.12. Survey: Fiscal 2007 Biomarker-Related Budgetary Plans Figure 7.13. Survey: Three-Year Biomarker-Related Budgetary Plans